c-Met pathway in human malignancies and its targeting by natural compounds for cancer therapy

Author:

Mohan Chakrabhavi Dhananjaya,Shanmugam Muthu KORCID,Gowda Siddegowda Gopalapura Shivanne,Chinnathambi Arunachalam,Rangappa Kanchugarakoppal S.,Sethi Gautam

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference195 articles.

1. Anticancer potential of curcumin: preclinical and clinical studies;Aggarwal;Anticancer research,2003

2. Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studies;Alhazzani;Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society,2023

3. Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors;Aliebrahimi;Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2018

4. A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation;An;Cell death & disease,2023

5. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds;Ang;Medicinal research reviews,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3